Published in Adv Exp Med Biol on January 01, 2003
The Cys214-->Ser mutation in peripherin/rds causes a loss-of-function phenotype in transgenic mice. Biochem J (2005) 1.28
The function of oligomerization-incompetent RDS in rods. Adv Exp Med Biol (2010) 0.78
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet (2011) 6.09
Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med (2012) 5.64
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol (2007) 3.25
Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A (2011) 3.23
Dementia with Lewy bodies. Lancet Neurol (2004) 2.66
Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr (2011) 2.16
Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci (2004) 1.92
Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids. Neuron (2007) 1.85
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. BMJ (2005) 1.54
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med (2007) 1.52
Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy. Hum Mol Genet (2011) 1.47
Antipsychotics for people with dementia. BMJ (2008) 1.45
Implementation of a telepharmacy service to provide round-the-clock medication order review by pharmacists. Am J Health Syst Pharm (2010) 1.43
Dopamine-stimulated dephosphorylation of connexin 36 mediates AII amacrine cell uncoupling. J Neurosci (2009) 1.43
2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? Cerebrovasc Dis (2011) 1.40
Modulating expression of peripherin/rds in transgenic mice: critical levels and the effect of overexpression. Invest Ophthalmol Vis Sci (2004) 1.32
Targeted expression of Cre recombinase to cone photoreceptors in transgenic mice. Mol Vis (2004) 1.31
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol (2006) 1.29
The Cys214-->Ser mutation in peripherin/rds causes a loss-of-function phenotype in transgenic mice. Biochem J (2005) 1.28
Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord (2003) 1.27
White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke (2004) 1.26
Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int J Geriatr Psychiatry (2010) 1.26
Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study. Cerebrovasc Dis (2009) 1.25
Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord (2014) 1.21
Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc Dis (2006) 1.20
Overexpression of rhodopsin alters the structure and photoresponse of rod photoreceptors. Biophys J (2009) 1.18
G-protein-coupled receptor rhodopsin regulates the phosphorylation of retinal insulin receptor. J Biol Chem (2007) 1.17
Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry (2007) 1.17
Native cone photoreceptor cyclic nucleotide-gated channel is a heterotetrameric complex comprising both CNGA3 and CNGB3: a study using the cone-dominant retina of Nrl-/- mice. J Neurochem (2008) 1.17
Connexin 35/36 is phosphorylated at regulatory sites in the retina. Vis Neurosci (2007) 1.15
Differential requirements for retinal degeneration slow intermolecular disulfide-linked oligomerization in rods versus cones. Hum Mol Genet (2008) 1.15
Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial). Am J Geriatr Psychiatry (2009) 1.14
Light induces programmed cell death by activating multiple independent proteases in a cone photoreceptor cell line. Invest Ophthalmol Vis Sci (2007) 1.13
Outer segment oligomerization of Rds: evidence from mouse models and subcellular fractionation. Biochemistry (2008) 1.12
Photoreceptor coupling is controlled by connexin 35 phosphorylation in zebrafish retina. J Neurosci (2009) 1.11
P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice. Invest Ophthalmol Vis Sci (2003) 1.10
Lack of protein-tyrosine sulfation disrupts photoreceptor outer segment morphogenesis, retinal function and retinal anatomy. Eur J Neurosci (2010) 1.08
Construction of a 'unigene' cDNA clone set by oligonucleotide fingerprinting allows access to 25 000 potential sugar beet genes. Plant J (2002) 1.08
Is late onset depression a prodrome to dementia? Int J Geriatr Psychiatry (2002) 1.08
Adenosine and dopamine receptors coregulate photoreceptor coupling via gap junction phosphorylation in mouse retina. J Neurosci (2013) 1.07
Protein kinase A mediates regulation of gap junctions containing connexin35 through a complex pathway. Brain Res Mol Brain Res (2005) 1.07
Mild cognitive impairment should be considered for DSM-V. J Geriatr Psychiatry Neurol (2006) 1.06
MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study. Cerebrovasc Dis (2009) 1.04
Regulation of gap junction coupling through the neuronal connexin Cx35 by nitric oxide and cGMP. Cell Commun Adhes (2006) 1.03
Molecular and functional asymmetry at a vertebrate electrical synapse. Neuron (2013) 1.03
Multiple neuronal connexins in the mammalian retina. Cell Commun Adhes (2003) 1.02
Nonsynaptic NMDA receptors mediate activity-dependent plasticity of gap junctional coupling in the AII amacrine cell network. J Neurosci (2012) 1.02
Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Am Geriatr Soc (2006) 1.01
Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J Biol Chem (2004) 1.01
Regulation of neuronal connexin-36 channels by pH. Proc Natl Acad Sci U S A (2008) 1.00
Retinal abnormalities associated with the G90D mutation in opsin. J Comp Neurol (2004) 1.00
Endoplasmic reticulum stress-associated cone photoreceptor degeneration in cyclic nucleotide-gated channel deficiency. J Biol Chem (2012) 1.00
Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study. J Am Geriatr Soc (2008) 1.00
cGMP accumulation causes photoreceptor degeneration in CNG channel deficiency: evidence of cGMP cytotoxicity independently of enhanced CNG channel function. J Neurosci (2013) 0.99
Coupling between A-type horizontal cells is mediated by connexin 50 gap junctions in the rabbit retina. J Neurosci (2006) 0.99
Early-onset, slow progression of cone photoreceptor dysfunction and degeneration in CNG channel subunit CNGB3 deficiency. Invest Ophthalmol Vis Sci (2011) 0.98
Vascular basis of late-onset depressive disorder. Br J Psychiatry (2002) 0.98
Molecular characterization of the skate peripherin/rds gene: relationship to its orthologues and paralogues. Invest Ophthalmol Vis Sci (2003) 0.97
Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor. Mol Pharmacol (2003) 0.97
Deterioration of gait and balance over time: the effects of age-related white matter change--the LADIS study. Cerebrovasc Dis (2013) 0.96
Efficient depletion of host DNA contamination in malaria clinical sequencing. J Clin Microbiol (2012) 0.96
Calcium-dependent binding of calmodulin to neuronal gap junction proteins. Biochem Biophys Res Commun (2005) 0.96
Profile of neuropsychological deficits in older stroke survivors without dementia. Dement Geriatr Cogn Disord (2003) 0.95
Protein tyrosine-O-sulfation in bovine ocular tissues. Adv Exp Med Biol (2012) 0.95
A review of acrylamide: an industry perspective on research, analysis, formation, and control. Crit Rev Food Sci Nutr (2004) 0.95
Deletion of smooth muscle alpha-actin alters blood-retina barrier permeability and retinal function. Invest Ophthalmol Vis Sci (2006) 0.93
Retinoid processing in cone and Müller cell lines. Exp Eye Res (2007) 0.93
Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dement Geriatr Cogn Disord (2002) 0.93
A network collaboration implementing technology to improve medication dispensing and administration in critical access hospitals. J Am Med Inform Assoc (2010) 0.92
Photoreceptor coupling mediated by connexin36 in the primate retina. J Neurosci (2012) 0.91
Functional expression of cone cyclic nucleotide-gated channel in cone photoreceptor-derived 661W cells. Adv Exp Med Biol (2008) 0.91
Salivary endothelin-1 potential for detecting oral cancer in patients with oral lichen planus or oral cancer in remission. Oral Oncol (2011) 0.90
Suppressing thyroid hormone signaling preserves cone photoreceptors in mouse models of retinal degeneration. Proc Natl Acad Sci U S A (2014) 0.90
Rhodopsin: the functional significance of asn-linked glycosylation and other post-translational modifications. Ophthalmic Genet (2009) 0.90
Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist. Mol Pharmacol (2004) 0.90
Photoreceptor cells constitutively express functional TLR4. J Neuroimmunol (2011) 0.89
The disease-causing mutations in the carboxyl terminus of the cone cyclic nucleotide-gated channel CNGA3 subunit alter the local secondary structure and interfere with the channel active conformational change. Biochemistry (2010) 0.89
Cones respond to light in the absence of transducin β subunit. J Neurosci (2013) 0.89
Absence of functional and structural abnormalities associated with expression of EGFP in the retina. Invest Ophthalmol Vis Sci (2004) 0.88
Intracellular magnesium-dependent modulation of gap junction channels formed by neuronal connexin36. J Neurosci (2013) 0.87
Language impairment in dementia: impact on symptoms and care needs in residential homes. Int J Geriatr Psychiatry (2003) 0.86
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. Trials (2009) 0.86
Congenital sacrococcygeal PNET and chemotherapy. Indian J Med Paediatr Oncol (2012) 0.86
Does telecare prolong community living in dementia? A study protocol for a pragmatic, randomised controlled trial. Trials (2013) 0.86
Hyperintensities and fronto-subcortical atrophy on MRI are substrates of mild cognitive deficits after stroke. Dement Geriatr Cogn Disord (2003) 0.86
Integrated protein array screening and high throughput validation of 70 novel neural calmodulin-binding proteins. Mol Cell Proteomics (2010) 0.86
Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities. Int J Geriatr Psychiatry (2002) 0.85
Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease. J Chem Neuroanat (2003) 0.85
Synthetic self-assembling clostridial chimera for modulation of sensory functions. Bioconjug Chem (2013) 0.85
Assembly of protein building blocks using a short synthetic peptide. Bioconjug Chem (2012) 0.85